Table 4.
EPIC questionnaire scores
| All patients (n = 26) | S-IL-2 (n = 13) | M-IL-2 (n = 13) | P-value | |
|---|---|---|---|---|
| Mean summary scores (s.d.) | ||||
| Urinary | 88.3 (11.6) | 87.9 (12.7) | 88.7 (10.9) | 0.97 |
| Bowel | 85.8 (14.0) | 82.4 (16.7) | 89.1 (10.1) | 0.51 |
| Sexual | 41.2 (24.7) | 39.9 (22.1) | 42.6 (28.0) | 0.81 |
| Hormonal | 84.6 (14.2) | 83.1 (16.1) | 86.1 (12.6) | 0.60 |
| Domain-specific subscales | ||||
| Urinary Function | 92.4 (12.5) | 91.4 (12.0) | 93.3 (13.4) | 0.33 |
| Bother | 84.2 (13.0) | 84.3 (14.5) | 84.1 (12.0) | 0.71 |
| Incontinence | 87.6 (19.1) | 87.4 (14.3) | 87.8 (23.6) | 0.43 |
| Irritation/obstruction | 88.5 (10.1) | 88.2 (11.7) | 88.7 (8.7) | 0.87 |
| Bowel | ||||
| Function | 86.8 (11.9) | 84.3 (13.5) | 89.3 (10.1) | 0.40 |
| Bother | 84.8 (17.3) | 80.5 (21.2) | 89.0 (11.7) | 0.41 |
| Sexual | ||||
| Function | 30.1 (24.9) | 27.1 (24.8) | 32.8 (25.8) | 0.55 |
| Bother | 53.5 (32.7) | 56.3 (27.8) | 50.5 (38.3) | 0.62 |
| Hormonal | ||||
| Function | 83.1 (15.5) | 82.7 (17.2) | 83.5 (14.3) | 0.99 |
| Bother | 86.2 (15.9) | 83.6 (16.8) | 88.8 (15.2) | 0.27 |
Abbreviations: EPIC, expanded prostate cancer index composite; IL, interleukin; M-IL-2, metronomic dose IL-2; S-IL-2, standard dose IL-2.